Anthony West, who finished runner up at the last two Moto2 Grand Prix races, faces a one month suspension from racing after failing a random drugs test earlier in the season at the French Grand Prix.
At Le Mans the Australian finished seventh and he has now been disqualified from that result and the points stripped.
West failed his test for Methylhexanemine, a product originally developed for nasal decongestant but in recent years it has also been used as a dietary aid to promote weight loss. In Moto2 rider weight is clearly a major issue with no minimum weight for bike and rider. As a result it is crucial for riders to lose weight so that in a category with stock engines that they do not suffer from poor power to weight ratios.
It also raises a users heart rate and as a result can provide extra energy upon consumption which offers the ability to train harder and longer. An additional side effect is a heightened sense of awareness which would obviously offer a motorcycle racer benefits in the course of a race.
The FIM today released the following statement following their decision:
The sample of Australian Moto2 class rider Anthony West contained Methylhexaneamine, a substance included in ‘S.6b Specified Stimulants’ prohibited in competition, and thereby infringed Art 2.1 of the 2012 FIM Anti-Doping Code.
Following the hearing of the rider, the CDI decided to disqualify Anthony West from the French round of the 2012 FIM Moto2 World Championship, held on 20 May in Le Mans. In addition, the CDI imposes on the rider a sanction of one month’s period of ineligibility to compete in any meeting authorised or organised by the FIM or any FIM-affiliated federation or body or in any competitions authorised or organised by any international or national level meeting organisation, from 30 October 2012.
An appeal may be lodged with the International Tribunal of Appeal (TIA) within 5 day as from the notification of the decision.